Skip to main content
Rachel Hu, MD, Oncology, Murray, UT, Intermountain Medical Center

RachelHuMD

Oncology Murray, UT

Hematologic Oncology

Director of Hematologic Malignancies

Overview of Dr. Hu

Dr. Rachel Hu is an oncologist in Murray, UT and is affiliated with Intermountain Medical Center. She received her medical degree from University of Missouri-Columbia School of Medicine and has been in practice 2 years. She is one of 55 doctors at Intermountain Medical Center who specialize in Oncology. She has 8 publications and over 50 citings.

Education & Training

  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationChief Fellow, Hematology/Oncology, 2018 - 2020
  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationFellowship, Hematology and Medical Oncology, 2017 - 2020
  • Duke University Hospital
    Duke University HospitalResidency, Internal Medicine, 2014 - 2017
  • Duke University Hospital
    Duke University HospitalInternship, Internal Medicine, 2014 - 2015
  • University of Missouri-Columbia School of Medicine
    University of Missouri-Columbia School of MedicineClass of 2014
  • Purdue University
    Purdue UniversityBS, Pharmaceutical Sciences, Summa Cum Laude, 2006 - 2010

Certifications & Licensure

  • UT State Medical License
    UT State Medical License 2020 - 2026
  • NV State Medical License
    NV State Medical License 2022 - 2025
  • ID State Medical License
    ID State Medical License 2022 - 2024
  • WY State Medical License
    WY State Medical License 2022 - 2024
  • OH State Medical License
    OH State Medical License 2017 - 2021
  • NC State Medical License
    NC State Medical License 2014 - 2017
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Alpha Omega Alpha Honor Medical Society
  • Rho Chi Pharmacy Honor Society
  • Clinical Instructor Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, 2020

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Fitness and Anthracycline Use in Front-Line Therapy for Older Patients with Classical Hodgkin Lymphoma: A US Multi-Center Retrospective Analysis
    Rachel Hu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • Treatment Outcomes with Purine Nucleoside Analog Alone or with Rituximab for Hairy Cell Leukemia Patients at First Relapse: A Multi-Center Outcomes Analysis 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Differences in Genomic Patterns between African Americans and Whites with Acute Myeloid Leukemia 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Professional Memberships

Hospital Affiliations